glp-1 receptor agonists adverse effects are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. events are mostly gastrointestinal Clinical Focus on GLP-1 Agonists

Recent paper review L-carnitine and betaine supplementation Pet food manufacturers often supplement diets with various ingredients that target specific health conditions and help to differentiate their products from the competition

For instance, Dai et al

26 The authors observed that treatment of NK cells with a combination of IL-2, IL-12, and NAC caused a significant increase in NK cell cytolytic activity and, therefore, control of M

Mice were then divided into four weight-matched and liver function-matched groups (n=7 per group): NC group (C57BL/6 mice), Vehicle group (ob/ob mice), 50 mg/kg cinchonine group (ob/ob mice), and 100 mg/kg cinchonine group (ob/ob mice)

Vitamin A metabolites inhibit ferroptosis